Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities - Top-Institutions - MDSpire

Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities

  • By

  • Lidetian Hu

  • Haixing Cao

  • Yujie Zhang

  • Xiang Ma

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, Tennessee

    Key Differentiators

    • Pediatric Oncology
    • Retinoblastoma Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Ophthalmic Oncology

  • #3

    Dana-Farber Cancer Center
    Dana-Farber Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Neuro-Oncology

Original Source(s)

Commentary: Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities

  • by Lidetian Hu, Haixing Cao, Yujie Zhang, Xiang Ma

  • July 15, 2026

Related Content

GLA is associated with ESCC progression and chemotherapy response via DNA damage repair–related pathways

Mass Spec Roundup: Signals Recovered

This week’s stories span amino-metabolite imaging, site-specific HDX-MS, large-scale motif annotation, and proteomics missing-value recovery

  • July 15, 2026

  • 7 min
Colorectal Cancer Treatment Delay Thresholds and Metastasis Risk